Showing results (251-260 of 330) with videos related to

Sort By:
Pageof 33
JACC. Cardiooncology|April 22, 2026
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 PatientsEli Muchtar, Susan Geyer, Angela Dispenzieri, et al.
JACC. Cardiooncology|August 5, 2026
Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective: JACC CardioOncology State-of-the-Art ReviewGiulia Guerra, George Bianco, Alessandra Ghigo
JACC. Cardiooncology|July 15, 2026
Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights From Proteomic and Metabolomic MediatorsXixi Xiao, Jiayong Li, Yu Ning, et al.
JACC. Cardiooncology|October 21, 2020
Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing ChemotherapyMuthiah Vaduganathan, Sameer A Hirji, Arman Qamar, et al.
JACC. Cardiooncology|January 13, 2023
Correction
JACC. Cardiooncology|January 13, 2023
Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology PrimerSarju Ganatra, Sourbha S Dani, Eric H Yang, et al.
JACC. Cardiooncology|January 13, 2023
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art ReviewSean Tan, Daphne Day, Stephen J Nicholls, et al.
JACC. Cardiooncology|November 29, 2022
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic ValueAlberto Cipriani, Laura De Michieli, Aldostefano Porcari, et al.
JACC. Cardiooncology|November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure SymptomsEsther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
JACC. Cardiooncology|November 29, 2022
AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art ReviewAshutosh D Wechalekar, Marianna Fontana, C Cristina Quarta, et al.
Pageof 33